IDEXX Laboratories Inc IDXX
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1991-06-21 |
| Shares Out. | 78,880,000 |
| Website | idexx.com/ ↗ |
| Phone | 12075560300 |
| Employees | 11,000 |
| Revenue | $1.14B |
| Gross Profit | $722.7M |
| Net Income | $278.4M |
| Free Cash Flow | $1.08B |
| Total Assets | $3.39B |
| Total Liabilities | $1.83B |
| Equity | $1.56B |
About IDEXX Laboratories Inc
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
IDEXX Laboratories Inc is a publicly traded company under the ticker symbol IDXX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-07-01)

